196 related articles for article (PubMed ID: 8876252)
21. Combinatorial effects of the phytoestrogen genistein and of estradiol in uterus and liver of female Wistar rats.
Diel P; Hertrampf T; Seibel J; Laudenbach-Leschowsky U; Kolba S; Vollmer G
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):60-70. PubMed ID: 17049845
[TBL] [Abstract][Full Text] [Related]
22. The IGF system in the neonatal ovine uterus.
Hayashi K; Carpenter KD; Welsh TH; Burghardt RC; Spicer LJ; Spencer TE
Reproduction; 2005 Mar; 129(3):337-47. PubMed ID: 15749960
[TBL] [Abstract][Full Text] [Related]
23. Activation of a uterine insulin-like growth factor I signaling pathway by clinical and environmental estrogens: requirement of estrogen receptor-alpha.
Klotz DM; Hewitt SC; Korach KS; Diaugustine RP
Endocrinology; 2000 Sep; 141(9):3430-9. PubMed ID: 10965916
[TBL] [Abstract][Full Text] [Related]
24. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
Valverde AM; Lorenzo M; Pons S; White MF; Benito M
Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931
[TBL] [Abstract][Full Text] [Related]
25. Growth factor-specific regulation of insulin receptor substrate-1 expression in MCF-7 breast carcinoma cells: effects on the insulin-like growth factor signaling pathway.
Lassarre C; Ricort JM
Endocrinology; 2003 Nov; 144(11):4811-9. PubMed ID: 12960057
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat.
Murphy LJ; Friesen HG
Endocrinology; 1988 Jan; 122(1):325-32. PubMed ID: 3335211
[TBL] [Abstract][Full Text] [Related]
27. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.
Guvakova MA; Surmacz E
Exp Cell Res; 1997 Feb; 231(1):149-62. PubMed ID: 9056422
[TBL] [Abstract][Full Text] [Related]
28. Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acids 591-786.
Sawka-Verhelle D; Tartare-Deckert S; White MF; Van Obberghen E
J Biol Chem; 1996 Mar; 271(11):5980-3. PubMed ID: 8626379
[TBL] [Abstract][Full Text] [Related]
29. Insulin receptor substrate 3 (IRS-3) and IRS-4 impair IRS-1- and IRS-2-mediated signaling.
Tsuruzoe K; Emkey R; Kriauciunas KM; Ueki K; Kahn CR
Mol Cell Biol; 2001 Jan; 21(1):26-38. PubMed ID: 11113178
[TBL] [Abstract][Full Text] [Related]
30. Deletion of the pleckstrin and phosphotyrosine binding domains of insulin receptor substrate-2 does not impair its ability to regulate cell proliferation in myeloid cells.
Sun H; Baserga R
Endocrinology; 2004 Nov; 145(11):5332-43. PubMed ID: 15297443
[TBL] [Abstract][Full Text] [Related]
31. Growth hormone stimulates tyrosine phosphorylation of insulin receptor substrate-1.
Souza SC; Frick GP; Yip R; Lobo RB; Tai LR; Goodman HM
J Biol Chem; 1994 Dec; 269(48):30085-8. PubMed ID: 7527025
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin II modulates tyr-phosphorylation of IRS-4, an insulin receptor substrate, in rat liver membranes.
Villarreal RS; Alvarez SE; Ayub MJ; Ciuffo GM
Mol Cell Biochem; 2006 Dec; 293(1-2):35-46. PubMed ID: 16933034
[TBL] [Abstract][Full Text] [Related]
33. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612.
De Fea K; Roth RA
Biochemistry; 1997 Oct; 36(42):12939-47. PubMed ID: 9335553
[TBL] [Abstract][Full Text] [Related]
34. Insulin receptor substrate 1 mediates insulin and insulin-like growth factor I-stimulated maturation of Xenopus oocytes.
Chuang LM; Myers MG; Seidner GA; Birnbaum MJ; White MF; Kahn CR
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5172-5. PubMed ID: 7685118
[TBL] [Abstract][Full Text] [Related]
35. Antiinsulin receptor autoantibodies induce insulin receptors to constitutively associate with insulin receptor substrate-1 and -2 and cause severe cell resistance to both insulin and insulin-like growth factor I.
Auclair M; Vigouroux C; Desbois-Mouthon C; Deibener J; Kaminski P; Lascols O; Cherqui G; Capeau J; Caron M
J Clin Endocrinol Metab; 1999 Sep; 84(9):3197-206. PubMed ID: 10487687
[TBL] [Abstract][Full Text] [Related]
36. IRS-I expression on the luteinized rat ovary: IGF-I and cyclic AMP effects on IRS-I tyrosine phosphorylation.
Talavera F; Chen Z; Menon KM
Biochim Biophys Acta; 1996 Jan; 1310(1):10-8. PubMed ID: 9244169
[TBL] [Abstract][Full Text] [Related]
37. Involvement of insulin-like growth factor type 1 receptor and protein kinase Cdelta in bis(maltolato)oxovanadium(IV)-induced phosphorylation of protein kinase B in HepG2 cells.
Mehdi MZ; Vardatsikos G; Pandey SK; Srivastava AK
Biochemistry; 2006 Sep; 45(38):11605-15. PubMed ID: 16981720
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factor-I (IGF-I) dependent phosphorylation of the IGF-I receptor in MG-63 cells.
Lopaczynski W; Harris S; Nissley P
Regul Pept; 1993 Oct; 48(1-2):207-16. PubMed ID: 7505467
[TBL] [Abstract][Full Text] [Related]
39. Influence of estrogens on mouse uterine epidermal growth factor precursor protein and messenger ribonucleic acid.
DiAugustine RP; Petrusz P; Bell GI; Brown CF; Korach KS; McLachlan JA; Teng CT
Endocrinology; 1988 Jun; 122(6):2355-63. PubMed ID: 3286224
[TBL] [Abstract][Full Text] [Related]
40. Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats.
Saad MJ; Folli F; Kahn JA; Kahn CR
J Clin Invest; 1993 Oct; 92(4):2065-72. PubMed ID: 7691892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
